These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9702759)

  • 21. Intellectual property. Court tightens patent rules on gene tags.
    Kintisch E
    Science; 2005 Sep; 309(5742):1797-9. PubMed ID: 16166482
    [No Abstract]   [Full Text] [Related]  

  • 22. Process patent bill on track.
    Gershon D
    Nature; 1993 Jul; 364(6435):274. PubMed ID: 8332176
    [No Abstract]   [Full Text] [Related]  

  • 23. Biotechnology inventions in the health care environment: what to patent and how to avoid defeat.
    Murashige KR
    Benders Health Care Law Mon; 1995 Dec; ():3-10. PubMed ID: 10158648
    [No Abstract]   [Full Text] [Related]  

  • 24. Patent reform acts ugly.
    Nat Biotechnol; 2007 Nov; 25(11):1187. PubMed ID: 17989652
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intellectual property in higher life forms: the patent system and controversial technologies.
    Merges RP
    MD Law Rev; 1988; 47(4):1051-75. PubMed ID: 16514761
    [No Abstract]   [Full Text] [Related]  

  • 26. Have you bargained away patent rights? Inventors and entrepreneurs need to consider a recent Supreme Court ruling in their patent strategies.
    Baggot B
    Nat Biotechnol; 1999 Mar; 17(3):297-8. PubMed ID: 10096300
    [No Abstract]   [Full Text] [Related]  

  • 27. Cabilly patent finale.
    Waltz E
    Nat Biotechnol; 2008 Aug; 26(8):846. PubMed ID: 18688222
    [No Abstract]   [Full Text] [Related]  

  • 28. Japan joins efforts to patent cDNA clones.
    Saegusa A
    Nature; 1999 Oct; 401(6753):520. PubMed ID: 10524612
    [No Abstract]   [Full Text] [Related]  

  • 29. US court tests the breadth of patent protection on proteins.
    Wadman M
    Nature; 2000 Apr; 404(6778):532. PubMed ID: 10766203
    [No Abstract]   [Full Text] [Related]  

  • 30. US companies settle EPO patent suit.
    Gershon D
    Nature; 1993 May; 363(6426):196. PubMed ID: 8487853
    [No Abstract]   [Full Text] [Related]  

  • 31. Europe's patent rebellion.
    Wadman M
    Fortune; 2001 Oct; 144(6):44. PubMed ID: 11586878
    [No Abstract]   [Full Text] [Related]  

  • 32. US to rule on research patent.
    Ruttimann J
    Nature; 2006 Mar; 440(7084):587. PubMed ID: 16572133
    [No Abstract]   [Full Text] [Related]  

  • 33. Hatch-waxman changes debated.
    Chahine K
    Nat Biotechnol; 2000 Jul; 18(7):710-1. PubMed ID: 10888831
    [No Abstract]   [Full Text] [Related]  

  • 34. Patent fight sparks biological warfare in the drug industry.
    Fortune; 2000 Jul; 142(3):40, 42. PubMed ID: 11066662
    [No Abstract]   [Full Text] [Related]  

  • 35. DNA patentability--anything but obvious.
    Dillen JS
    Wis L Rev; 1997; 5():1023-46. PubMed ID: 16329221
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Collaborative research presents special problems for patent seekers.
    Thorne LW; Ergenzinger ER; Spruill WM
    Nat Biotechnol; 2004 Jul; 22(7):901-2. PubMed ID: 15229550
    [No Abstract]   [Full Text] [Related]  

  • 37. A guide to drug discovery. Protecting your inventions: the patent system.
    Webber PM
    Nat Rev Drug Discov; 2003 Oct; 2(10):823-30. PubMed ID: 14526385
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Supreme Court boosts licensees in biotech patent battles.
    Waltz E
    Nat Biotechnol; 2007 Mar; 25(3):264-5. PubMed ID: 17344866
    [No Abstract]   [Full Text] [Related]  

  • 39. Intellectual property. Decision on NFkappaB patent could have broad implications for biotech.
    Garber K
    Science; 2006 May; 312(5775):827. PubMed ID: 16690824
    [No Abstract]   [Full Text] [Related]  

  • 40. The coming US patent opposition.
    Apple T
    Nat Biotechnol; 2005 Feb; 23(2):245-7. PubMed ID: 15696151
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.